Search Results - "Jokaji, H."

Role of tissue factor in disseminated intravascular coagulation by Asakura, H., Kamikubo, Y., Goto, A., Shiratori, Y., Yamazaki, M., Jokaji, H., Saito, M., Uotani, C., Kumabashiri, I., Morishita, E., Aoshima, K., Nakamura, S., Matsuda, T.

“…We examined plasma antigen levels of tissue factor (TF) in 95 cases of disseminated intravascular coagulation (DIC), to investigate the role of TF in DIC. A…”
Get full text

Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation by Asakura, H, Hifumi, S, Jokaji, H, Saito, M, Kumabashiri, I, Uotani, C, Morishita, E, Yamazaki, M, Shibata, K, Mizuhashi, K

“…It is well known that atrial fibrillation (AF) is one of the most important diseases that predispose patients to thrombosis. We have attempted to identify…”
Get more information

Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Aoshima, K, Ikeda, T, Matsuda, T

“…The mechanisms underlying clinical abnormalities associated with the antiphospholipid antibody syndrome (APAS) have not been elucidated. We measured plasma…”
Get more information

Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats by Yamazaki, M, Asakura, H, Aoshima, K, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Ikeda, T, Matsuda, T

“…We investigated the protective effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against two kinds of experimental…”
Get more information

Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Aoshima, K, Matsuda, T

“…Plasma levels of thrombin-antithrombin III complex (TAT), plasmin-alpha 2-plasmin inhibitor complex (PIC) and active plasminogen activator inhibitor (PAI) were…”
Get more information

Intrapleural corticosteroid injection therapy for post-traumatic eosinophilic pleural effusion by Ishiura, Y., Fujimura, M., Nakamura, N., Jokaji, H., Minami, S., Matsuda, T.

Get full text

Role of endothelin in disseminated intravascular coagulation by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…We examined the changes in plasma levels of endothelin-1 (ET-1), a potent vasoconstrictor peptide, in 47 cases of disseminated intravascular coagulation (DIC)…”
Get more information

Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Aoshima, K, Matsuda, T

“…The purpose of this pilot study was to determine the effect of recombinant hirudin (r-hirudin) on coagulopathy and the relationship between concentrations of…”
Get more information

Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine by Morishita, E, Nakao, S, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Yamazaki, M, Yoshida, T, Takemoto, K, Aoshima, K, Hashimoto, T, Matsuda, T

“…There is some clinical evidence that cyclosporine A (CyA) is associated with thrombotic complications of bone marrow and renal transplantation. We investigated…”
Get more information

Levels of Activated Factor VII in Patients With Disseminated Intravascular Coagulation by Saito, Masanori, Asakura, Hidesaku, Yoshida, Tomotaka, Jokaji, Hiroshi, Uotani, Chika, Kumabashiri, Ichiro, Morishita, Eriko, Yamazaki, Masahide, Aoshima, Keiji, Matsuda, Tamotsu

Get full text

Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Nakamura, S, Naito, T, Ohta, H

“…We report a 74-year-old Japanese woman who had bleeding due to a factor VIII inhibitor in the absence of diseases known to be associated with its development…”
Get more information

Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia by NAKAMURA, N, HAMAZAKI, T, JOKAJI, H, MINAMI, S, KOBAYASHI, M

“…We investigated the effect of 12 months' HMG-CoA reductase inhibitor treatment on plasma polyunsaturated fatty acid concentrations in 19 patients with…”
Get full text

The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin? by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…Changes in thrombin-antithrombin III complex (TAT) over a one week period studied in 42 cases of disseminated intravascular coagulation (DIC); 19 treated with…”
Get more information

Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases by Saito, M, Morishita, E, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Aoshima, K, Matsuda, T

“…We measured plasma levels of tissue factor (TF), total tissue factor pathway inhibitor (TFPI) and free TFPI antigen in patients with diabetes mellitus (DM),…”
Get more information

Activation of intravascular coagulation and fibrinolysis in cases of APL by Asakura, H, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Matsuda, T

Get more information

Leukemia and pre-DIC--coagulation and fibrinolytic parameters in severe infection at the nadir of leukocyte after chemotherapy by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

Get more information

Hypercoagulability during the recovery period of leukocyte count after chemotherapy by Saito, M, Asakura, H, Uotani, C, Jokaji, H, Kumabashiri, I, Matsuda, T

Get more information

Mechanism on disorders of coagulation and fibrinolysis in diabetes by MATSUDA, T, MORISHITA, E, JOKAJI, H, ASAKURA, H, SAITO, M, YOSHIDA, T, TAKEMOTO, K.-I

“…Determination of various important parameters of coagulation and fibrinolysis, clinical characteristics, and levels of serum lipid were compared in 193…”
Get full text

Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus by Morishita, Eriko, Asakura, Hidesaku, Jokaji, Hiroshi, Saito, Masanori, Uotani, Chika, Kumabashiri, Ichiro, Yamazaki, Masahide, Aoshima, Keiji, Hashimoto, Takuma, Matsuda, Tamotsu

“…Diabetes mellitus is associated with disturbances in hemostasis that could contribute to the development of diabetic vascular disease. We investigated the…”
Get full text

Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…We examined the changes in plasma levels of soluble thrombomodulin in 66 cases of disseminated intravascular coagulation (DIC), to investigate the damage to…”
Get more information